Stress echocardiography for the assessment of myocardial ischemia and viability

Current Problems in Cardiology

Volumn 21, Issue 7, 1996, Pages 445-520

  Nagueh, Sherif F ^a   Zoghbi, William A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; DIAGNOSTIC AGENT; DIPYRIDAMOLE; THALLIUM;

AGED; ANIMAL; ARTICLE; ECHOCARDIOGRAPHY; ECHOGRAPHY; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEART CONTRACTION; HEART MUSCLE ISCHEMIA; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; SEXUAL DEVELOPMENT; STRESS;

AGED; ANIMALS; CATECHOLAMINES; DIPYRIDAMOLE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIAL ISCHEMIA; SENSITIVITY AND SPECIFICITY; SEX CHARACTERISTICS; STRESS; THALLIUM RADIOISOTOPES;

EID: 85045533697     PISSN: 01462806     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0146-2806(96)80006-5     Document Type: Review

References (208)

1. Kraunz RF, Kennedy JW. Ultrasonic determination of left ventricular wall motion in normal man: studies at rest and after exercise. Am Heart J 1970;79:36-43.
2. Crawford MH, White DH, Wray AK. Echocardiographic evaluation of left ventricular size and performance during handgrip and supine and upright bicycle exercise. Circulation 1979;59:1188-96.
3. Mason SJ, Weiss JL, Weisfeldt ML, et al. Exercise echocardiography: detection of wall motion abnormalities during ischemia. Circulation 1979;59:50-9.
4. Wann LS, Faris JV, Childress RH, et al. Exercise cross-sectional echocardiography in ischemic heart disease. Circulation 1979;60:1300-8.
5. Zwehl W, Gueret P, Meerbaum S, et al. Quantitative two-dimensional echocardiography during bicycle exercise in normal subjects. Am J Cardiol 1981;47:866-73.
6. Maurer G, Nanda NC. Two-dimensional echocardiographic evaluation of exercise-induced left and right ventricular asynergy: correlation with thallium scanning. Am J Cardiol 1981;48:720-7.
7. Limacher MC, Quinones MA, Poliner LS, et al. Detection of coronary artery disease with exercise two-dimensional echocardiography: description of a clinically applicable method and comparison with radionuclide ventriculography. Circulation 1983;67:1211-8.
8. Waggoner AD, Shah AA, Schuessler JS, et al. Effect of cardiac surgery on ventricular septal motion: assessment by intraoperative echocardiography and cross-sectional two-dimensional echocardiography. Am Heart J 1982;104:1271-8.
9. Harrison MR, Smith MD, Friedman BJ, et al. Uses and limitations of exercise Doppler echocardiography in the diagnosis of ischemic heart disease. J Am Coll Cardiol 1987;10:809-17.
10. Presti CF, Walling AD, Montemayor I, et al. Influence of exercise-induced myocardial ischemia on the pattern of left ventricular diastolic filling: a Doppler echocardiographic study. J Am Coll Cardiol 1991;18:75-82.
11. Voelker W, Jacksch R, Dittman H, et al. Validation of continuous-wave Doppler measurements of mitral valve gradients during exercise - a simultaneous Doppler catheter study. Eur Heart J 1989;10:737-46.
12. Tunick PA, Freedberg RS, Gargiulo A, et al. Exercise Doppler echocardiography as an aid to clinical decision making in mitral valve disease. J Am Soc Echocardiogr 1992;5:225-30.
13. deFilippi CR, Willett DL, Brickner ME, et al. Usefulness of dobutamine echocardiography in distinguishing severe from nonsevere valvular aortic stenosis in patients with depressed left ventricular function and low transvalvular gradients. Am J Cardiol 1995;75:191-4.
14. Chan KL, Currie PJ, Seward JB, et al. Comparison of three Doppler ultrasound methods in the prediction of pulmonary artery pressure. J Am Coll Cardiol 1987;9:549-54.
15. Himelman RB, Stulbarg M, Kircher B, et al. Noninvasive evaluation of pulmonary artery pressure during exercise by saline enhanced Doppler echocardiography in chronic pulmonary disease. Circulation 1989;79:863-71.
16. Homans DC, Sublett E, Dai XZ, et al. Persistence of regional left ventricular dysfunction after exercise induced myocardial ischemia. J Clin Invest 1986;77:66-73.
17. Robertson SW, Feigenbaum H, Armstrong WF, et al. Exercise echocardiography: a clinically practical addition in the evaluation of coronary artery disease. J Am Coll Cardiol 1983;2:1085-91.
18. Ellstead MH. Stress testing: principles and practice. 3rd ed. Philadelphia: FA Davis, 1986:157-85.
19. Ryan T, Segar DS, Sawada SG. Detection of coronary artery disease with upright bicycle exercise echocardiography. J Am Soc Echocardiogr 1993;6:186-97.
20. Hecht HA, DeBord L, Shaw R. Supine bicycle stress echocardiography versus tomographic thallium-201 exercise imaging for the detection of coronary artery disease. J Am Soc Echocardiogr 1993;6:177-85.
21. Quiñones MA. Technical considerations in exercise echocardiography: preference of exercise methodology, imaging approach, and comparison with radionuclide techniques. Coron Artery Dis 1991;2:536-42.
22. Huang ZH, Long WY, Xie GY, et al. Comparison of gray-scale and B-color ultrasound images in evaluating left ventricular systolic function in coronary artery disease. Am Heart J 1992;123:395-402.
23. Schiller NB, Shah PM, Crawsford M. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-67.
24. Quiñones MA, Waggoner AD, Reduto LA, et al. A new, simplified and accurate method for determining ejection fraction with two-dimensional echocardiography. Circulation 1981;64:744-53.
25. Morganroth J, Chen CC, David D, et al. Exercise cross-sectional echocardiographic diagnosis of coronary artery disease. Am J Cardiol 1981;47:20-6.
26. Visser CA, van der Wieken RL, Kan G, et al. Comparison of two-dimensional echocardiography with radionuclide angiography during dynamic exercise for the detection of coronary artery disease. Am Heart J 1983;106:528-34.
27. Quiñones MA, Verani MS, Haichin RN, et al. Exercise echocardiography versus thallium-201 single photon emission computed tomography in the evaluation of coronary artery disease: analysis of 292 patients. Circulation 1992;85:1026-31.
28. Marwick TH, Nemec JJ, Pashkow FJ, et al. Accuracy and limitations of exercise echocardiography in a routine clinical setting. J Am Coll Cardiol 1992;19:74-81.
29. Beleslin BD, Ostojic M, Stepanovic J, et al. Stress echocardiography in the detection of myocardial ischemia: head-to-head comparison of exercise, dobutamine, and dipyridamole tests. Circulation 1994;90:1168-76.
30. Dagianti A, Penco M, Agati L, et al. Stress echocardiography: comparison of exercise, dipyridamole, and dobutamine in detecting and predicting the extent of coronary artery disease. J Am Coll Cardiol 1995;26:18-25.
31. Armstrong WF, O'Donnell J, Ryan T, et al. Effect of prior myocardial infarction and extent and location of coronary disease on accuracy of exercise echocardiography. J Am Coll Cardiol 1987;10:531-8.
32. Crouse LJ, Harbrecht JJ, Vacek JL, et al. Exercise echocardiography as a screening test for coronary artery disease and correlation with coronary arteriography. Am J Cardiol 1991;67:1213-8.
33. Sawada SG, Ryan T, Feinberg NS, et al. Exercise echocardiographic detection of coronary artery disease in women. J Am Coll Cardiol 1989;14:1440-7.
34. Pozzoli MM, Fioretti PM, Salustri A, et al. Exercise echocardiography and technetium-99m MIBI single-photon emission computed tomography in the detection of coronary artery disease. Am J Cardiol 1991;67:350-5.
35. Hecht HS, DeBord L, Shaw R, et al. Digital supine bicycle stress echocardiography: a new technique for evaluating coronary artery disease. J Am Coll Cardiol 1993;21:950-6.
36. Sheikh KH, Bengtson JR, Helmy S, et al. Relation of quantitative coronary lesion measurements to the development of exercise induced ischemia assessed by exercise echocardiography. J Am Coll Cardiol 1990;15:1043-51.
37. Mahmarian JJ, Boyce TM, Goldberg RK, et al. Quantitative exercise thallium-201 single photon emission computed tomography for the enhanced diagnosis of ischemic heart disease. J Am Coll Cardiol 1990;15:318-29.
38. Presti C, Feigenbaum H, Armstrong WF. Comparison of echocardiography at peak exercise and after bicycle exercise in evaluation of patients with known or suspected CAD. J Am Soc Echocardiogr 1988;1:119-26.
39. Rifkin RD, Hood WB Jr. Bayesian analysis of electrocardiographic exercise stress testing. N Engl J Med 1977;297:681-6.
40. Wenger NK, Speroff L, Packard B. Cardiovascular health and disease in women [review]. N Engl J Med 1993;329:247-56.
41. Guiteras P, Chaitman BR, Waters DD, et al. Diagnostic accuracy of exercise ECG lead systems in clinical subsets of women. Circulation 1982;65:1465-74.
42. Marwick TH, Anderson T, Williams MJ, et al. Exercise echocardiography is an accurate and cost-efficient technique for detection of coronary artery disease in women. J Am Coll Cardiol 1995;26:335-41.
43. Williams KA, Taillon LA. Left ventricular function in patients with coronary artery disease assessed by gated tomographic myocardial perfusion images: comparison with assessment by contrast ventriculography and first-pass radionuclide angiography. J Am Coll Cardiol 1996;27:173-81.
44. Verani MS, Zoghbi WA. Comparison of scintigraphic and echocardiographic methods in coronary artery disease. Am J Card Imaging 1992;6:71-82.
45. Rozanski A, Diamond GA, Berman D, et al. The declining specificity of exercise radionuclide ventriculography. N Engl J Med 1983;309:518-22.
46. Galanti G, Sciagra R, Comeglio M, et al. Diagnostic accuracy of peak exercise echocardiography in coronary artery disease: comparison with thallium-201 myocardial scintigraphy. Am Heart J 1991;122:1609-16.
47. Lieberman AN, Weiss JL, Jugdutt BI. Two-dimensional echocardiography and infarct size: relationship of regional wall motion and thickening to the extent of myocardial infarction in the dog. Circulation 1981;63:739-46.
48. Kerber RE, Marcus ML, Ehrhardt J, et al. Correlation between echocardiographically demonstrated segmental dyskinesis and regional myocardial perfusion. Circulation 1975;52:1097-104.
49. Verani MS, Jhingran S, Attar M, et al. Poststress redistribution of thallium-201 in patients with coronary artery disease, with and without prior myocardial infarction. Am J Cardiol 1979;43:1114-22.
50. Yang LD, Berman DS, Kiat H, et al. The frequency of late reversibility in SPECT thallium-201 stress-redistribution studies. J Am Coll Cardiol 1990;15:334-40.
51. Grunwald AM, Watson DD, Holzgrefe HH Jr, et al. Myocardial thallium-201 kinetics in normal and ischemic myocardium. Circulation 1981;64:610-8.
52. Labovitz AJ, Lewen M, Kern MJ, et al. The effects of successful PTCA on left ventricular function: assessment by exercise echocardiography. Am Heart J 1989;117:1003-8.
53. Crouse LJ, Vacek JL, Beauchamp GD, et al. Exercise echocardiography after coronary artery bypass grafting. Am J Cardiol 1992;70:572-6.
54. Sawada SG, Judson WE, Ryan T, et al. Upright bicycle exercise echocardiography after coronary artery bypass graft. Am J Cardiol 1989;64:1123-9.
55. Jaarsma W, Visser CA, Funke Kupper AJ, et al. Usefulness of two-dimensional exercise echocardiography shortly after myocardial infarction. Am J Cardiol 1986;57:86-90.
56. Ryan T, Armstrong WF, O'Donnell JA, et al. Risk stratification after acute myocardial infarction by means of exercise two-dimensional echocardiography. Am Heart J 1987;114:1305-16.
57. Sawada SG, Ryan T, Conley MJ, et al. Prognostic value of a normal exercise echocardiogram. Am Heart J 1990;120:49-55.
58. Krivokapich J, Child JS, Gerber R, et al. Prognostic usefulness of positive or negative exercise stress echocardiography for predicting coronary events in ensuing twelve months. Am J Cardiol 1993;71:646-51.
59. Rivera JM, Khoury AF, Marks FG, et al. Long term prognostic value of exercise echocardiography in patients evaluated for coronary artery disease [abstract]. Circulation 1994;90:I-453.
60. Olmos LI, Gordon RJ, Dakik H, et al. Long term prognostic value of exercise echocardiography compared to thallium-201 perfusion imaging, electrocardiographic and clinical variables in patients evaluated for coronary artery disease [abstract]. Circulation 1995;92:I-411.
61. Zoghbi WA. Use of adenosine echocardiography for diagnosis of coronary artery disease. Am Heart J 1991;122:285-92.
62. FitzGerald GA. Dipyridamole [review]. N Engl J Med 1987;316:1247-57.
63. Verani MS. Pharmacologic myocardial perfusion imaging. J Myocard Ischemia 1993;5:31-41.
64. Klabunde RE. Dipyridamole inhibition of adenosine metabolism in human blood. Eur J Pharmacol 1983;93:21-6.
65. Homma S, Callahan RJ, Ameer B. Usefulness of oral dipyridamole suspension for stress thallium imaging without exercise in the detection of coronary artery disease. Am J Cardiol 1986;57:503-8.
66. Gould KL. Noninvasive assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilation. I. Physiologic basis and experimental validation. Am J Cardiol 1978;41:267-78.
67. Gould KL, Lipscomb K, Hamilton GW. Physiologic basis for assessing critical coronary stenosis: instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve. Am J Cardiol 1974;33:87-94.
68. Gross GJ, Warltier DC. Coronary steal in four models of single or multiple vessel obstruction in dogs. Am J Cardiol 1981;48:84-91.
69. Patterson RE, Kirk ES. Coronary steal mechanisms in dogs with one-vessel occlusion and other arteries normal. Circulation 1983;67:1009-15.
70. Picano E, Lattanzi F, Masini M, et al. High dose dipyridamole echocardiography test in effort angina pectoris. J Am Coll Cardiol 1986;8:848-54.
71. Beer SG, Heo J, Iskandrian AS. Dipyridamole thallium imaging [review]. Am J Cardiol 1991;67:18D-26D.
72. Cheirif JB, Zoghbi WA, Bolli R, et al. Assessment of regional myocardial perfusion by contrast echocardiography. II. Detection of changes in transmural and subendocardial perfusion during dipyridamole-induced hyperemia in a model of critical coronary stenosis. J Am Coll Cardiol 1989;14:1555-65.
73. Meerdink DJ, Okada RD, Leppo JA. The effect of dipyridamole on transmural blood flow gradients. Chest 1989;96:400-5.
74. Picano E, Distante A, Masini M, et al. Dipyridamole-echocardiography test in effort angina pectoris. Am J Cardiol 1985;56:452-6.
75. Picano E, Marini C, Pirelli S, et al. Safety of intravenous high-dose dipyridamole echocardiography: The Echo-Persantine International Cooperative Study Group. Am J Cardiol 1992;70:252-8.
76. Andrade MJ, Picano E, Pingitore A, et al. Dipyridamole stress echocardiography in patients with severe left main coronary artery narrowing: Echo Persantine International Cooperative (EPIC) Study Group - Subproject "Left Main Detection." Am J Cardiol 1994;73:450-5.
77. Mandysova E, Niederle P, Malkova A, et al. Usefulness of dipyridamole-handgrip echocardiography test for detecting coronary artery disease. Am J Cardiol 1991;67:883-5.
78. Brown BG, Lee AB, Bolson EL, et al. Reflex constriction of significant coronary stenosis as a mechanism contributing to ischemic left ventricular dysfunction during isometric exercise. Circulation 1984;70:18-24.
79. Picano E, Pingitore A, Conti U, et al. Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dipyridamole echocardiography. Eur Heart J 1993;14:1216-22.
80. Labovitz AJ, Pearson AC, Chaitman BR. Doppler and two-dimensional echocardiographic assessment of left ventricular function before and after intravenous dipyridamole stress testing for detection of coronary artery disease. Am J Cardiol 1988;62:1180-5.
81. Perin EC, Moore W, Blume M, et al. Comparison of dipyridamole-echocardiography with dipyridamole-thallium scintigraphy for the diagnosis of myocardial ischemia. Clin Nucl Med 1991;16:417-20.
82. Margonato A, Chierchia S, Cianflone D, et al. Limitations of dipyridamole-echocardiography in effort angina pectoris. Am J Cardiol 1987;59:225-30.
83. Agati L, Arata L, Neja CP, et al. Usefulness of the dipyridamole-Doppler test for diagnosis of coronary artery disease. Am J Cardiol 1990;65:829-34.
84. Mandysova E, Niederle P, Feuereisl R, et al. The dipyridamole echocardiography test combined with isometric loading in the diagnosis of ischemic heart disease. Cas Lek Cesk 1989;128:652-6.
85. Agati L, Renzi M, Sciomer S, et al. Transesophageal dipyridamole echocardiography for diagnosis of coronary artery disease. J Am Coll Cardiol 1992;19:765-70.
86. Pirelli S, Danzi GB, Alberti A, et al. Comparison of usefulness of high-dose dipyridamole echocardiography and exercise electrocardiography for detection of asymptomatic restenosis after coronary angioplasty. Am J Cardiol 1991;67:1335-8.
87. Mazeika P, Nihoyannopoulos P, Joshi J, et al. Uses and limitations of high dose dipyridamole stress echocardiography for evaluation of coronary artery disease. Br Heart J 1992;67:144-9.
88. Ostojic M, Picano E, Beleslin B, et al. Dipyridamole-dobutamine echocardiography: a novel test for the detection of milder forms of coronary artery disease. J Am Coll Cardiol 1994;23:1115-22.
89. Lattanzi F, Picano E, Bolognese L, et al. Inhibition of dipyridamole-induced ischemia by antianginal therapy in humans: correlation with exercise electrocardiography. Circulation 1991;83:1256-62.
90. Bongo AS, Bolognese L, Sarasso G, et al. Early assessment of coronary artery bypass graft patency by high-dose dipyridamole echocardiography. Am J Cardiol 1991;67:133-6.
91. Ferrara N, Bonaduce D, Leosco D, et al. Two-dimensional echocardiographic evaluation of ventricular asynergy induced by dipyridamole: correlation with thallium scanning. Clin Cardiol 1986;9:437-42.
92. Picano E, Severi S, Michelassi C, et al. Prognostic importance of dipyridamole echocardiography test in coronary artery disease. Circulation 1989;80:450-7.
93. Severi S, Picano E, Michelassi C, et al. Diagnostic and prognostic value of dipyridamole echocardiography in patients with suspected coronary artery disease: comparison with exercise electrocardiography. Circulation 1994;89:1160-73.
94. Bolognese L, Rossi L, Sarasso G. Silent versus symptomatic dipyridamole-induced ischemia after myocardial infarction: clinical and prognostic significance. J Am Coll Cardiol 1992;19:953-9.
95. Camerieri A, Picano E, Landi P, et al. Prognostic value of dipyridamole echocardiography early after myocardial infarction in elderly patients: Echo Persantine Italian Cooperative (EPIC) Study Group. J Am Coll Cardiol 1993;22:1809-15.
96. Drury AN, Szent-Gyorgyi A. The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart. J Physiol (Lond) 1929;68:213-37.
97. Bardenheuer H, Whelton B, Sparks HV Jr. Adenosine release by the isolated guinea pig heart in response to isoproterenol, acetylcholine, and acidosis: the minimal role of vascular endothelium. Circ Res 1987;61:594-600.
98. van Rugge FP, van der Wall EE, Bruschke AV. New developments in pharmacologic stress imaging [review]. Am Heart J 1992;124:468-85.
99. Belardinelli L, Linden J, Berne RM. The cardiac effects of adenosine [review]. Prog Cardiovasc Dis 1989;32:73-97.
100. Triner L, Nahas GG, Vulliemoz Y, et al. Cyclic AMP and smooth muscle function. Ann N Y Acad Sci 1971;185:458-76.
101. Kurtz A. Adenosine stimulates guanylate cyclase activity in vascular smooth muscle cells. J Biol Chem 1987;262:6296-300.
102. Moser GH, Schrader J, Deussen A. Turnover of adenosine in plasma of human and dog blood. Am J Physiol 1989;256:799-806.
103. Tao W, Mentzer RM Jr, Van Wylen DGL. Interstitial adenosine with dipyridamole: effect of adenosine receptor blockade and adenosine deaminase. Am J Physiol 1992;263:H552-8.
104. Wilson RF, Wyche K, Christensen BV, et al. Effects of adenosine on human coronary arterial circulation. Circulation 1990;82:1595-606.
105. Zoghbi WA, Cheirif J, Kleiman NS, et al. Diagnosis of ischemic heart disease using adenosine echocardiography. J Am Coll Cardiol 1991;18:1271-9.
106. Verani MS, Mahmarian JJ, Hixson JB, et al. Diagnosis of coronary artery disease by controlled coronary vasodilation with adenosine and thallium-201 scintigraphy in patients unable to exercise. Circulation 1990;82:80-7.
107. Cerqueira MD, Verani MS, Schwaiger M, et al. Safety profile of adenosine stress perfusion imaging: results from the Adenoscan Multicenter Trial Registry. J Am Coll Cardiol 1994;23:384-9.
108. Camm AJ, Garratt CJ. Adenosine and supraventricular tachycardia [review]. N Engl J Med 1991;325:1621-9.
109. 99mTc-MIBI single photon emission computed tomography. Circulation 1993;87:345-54.
110. Tawa CB, Baker WB, Kleiman NS, et al. Comparison of adenosine echocardiography, with and without isometric handgrip, to exercise echocardiography in the detection of ischemia in patients with coronary artery disease. J Am Soc Echocardiogr 1996;9:33-43.
111. Edlund A, Albertsson P, Caidahl K, et al. Adenosine infusion to patients with ischemic heart disease may provoke left ventricular dysfunction detected by echocardiography. Clin Physiol 1991;11:477-88.
112. Cheirif J, Zoghbi WA Adenosine echocardiography: a new pharmacologic stress test. Coron Artery Dis 1991;2:564-8.
113. Martin TW, Seaworth JF, Johns JP, et al. Comparison of adenosine, dipyridamole, and dobutamine in stress echocardiography. Ann Intern Med 1992;116:190-6.
114. Kujacic VG, Jablonskiene D, Emanuelsson HU. Adenosine echocardiography - an alternative to dynamic stress echocardiography. Int J Card Imaging 1993;9:169-77.
115. Amanullah AM, Bevegard S, Lindvall K, et al. Assessment of left ventricular wall motion in angina pectoris by two-dimensional echocardiography and myocardial perfusion by technetium-99m sestamibi tomography during adenosine-induced coronary vasodilation and comparison with coronary angiography. Am J Cardiol 1993;72:983-9.
116. Heinle S, Hanson M, Gracey L, et al. Correlation of adenosine echocardiography and thallium scintigraphy. Am Heart J 1993;125:1606-13.
117. LeJemtel TH, Katz SD, Scortichini D. Myocardial contractility and the effect of dobutamine on cardiac pump function: dobutamine. New York: NCM Publishers, 1989:69-79.
118. Kates RE, Leier CV. Dobutamine pharmacokinetics in severe heart failure. Clin Pharmacol Ther 1978;24:537-41.
119. Berthe C, Pierard LA, Hiernaux M, et al. Predicting the extent and location of coronary artery disease in acute myocardial infarction by echocardiography during dobutamine infusion. Am J Cardiol 1986;58:1167-72.
120. Sawada SG, Segar DS, Ryan T, et al. Echocardiographic detection of coronary artery disease during dobutamine infusion. Circulation 1991;83:1605-14.
121. Cohen JL, Green TO, Ottenweller J, et al. Dobutamine digital echocardiography for detecting coronary artery disease. Am J Cardiol 1991;67:1311-8.
122. Previtali M, Lanzarini L, Ferrario M, et al. Dobutamine versus dipyridamole echocardiography in coronary artery disease. Circulation 1991;83:III27-31.
123. Marcovitz PA, Armstrong WF. Accuracy of dobutamine stress echocardiography in detecting coronary artery disease. Am J Cardiol 1992;69:1269-73.
124. Marwick T, D'Hondt AM, Baudhuin T, et al. Optimal use of dobutamine stress for the detection and evaluation of coronary artery disease: combination with echocardiography or scintigraphy, or both? J Am Coll Cardiol 1993;22:159-67.
125. McNeill AJ, Fioretti PM, el-Said EM, et al. Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echo-cardiography. Am J Cardiol 1992;70:41-6.
126. Mertes H, Sawada SG, Ryan T, et al. Symptoms, adverse effects, and complications associated with dobutamine stress echocardiography: experience in 1118 patients. Circulation 1993;88:15-9.
127. Pellikka PA, Roger VL, Oh JK, et al. Stress echocardiography. Part II. Dobutamine stress echocardiography: techniques, implementation, clinical applications, and correlations [review]. Mayo Clin Proc 1995;70:16-27.
128. Rosamond TL, Vacek JL, Hurwitz A, et al. Hypotension during dobutamine stress echocardiography: initial description and clinical relevance. Am Heart J 1992;123:403-7.
129. Pellikka PA, Oh IK, Bailey KR, et al. Dynamic intraventricular obstruction during dobutamine stress echocardiography: anew observation. Circulation 1992;86:1429-32.
130. Afridi I, Kleiman NS, Raizner AE, et al. Dobutamine echocardiography in myocardial hibernation: optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation 1995;91:663-70.
131. Panza JA, Dilsizian V, Laurienzo JM, et al. Relation between thallium uptake and contractile response to dobutamine: implications regarding myocardial viability in patients with chronic coronary artery disease and left ventricular dysfunction. Circulation 1995;91:990-8.
132. Smart SC, Sawada S, Ryan T, et al. Low-dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction. Circulation 1993;88:405-15.
133. Olson CE, Porter TR, Deligonul U, et al. Left ventricular volume changes during dobutamine stress echocardiography identify patients with more extensive coronary artery disease. J Am Coll Cardiol 1994;24:1268-73.
134. Senior R, Lahiri A. Enhanced detection of myocardial ischemia by stress dobutamine echocardiography utilizing the biphasic response of wall thickening during low and high dose dobutamine infusion. J Am Coll Cardiol 1995;26:26-32.
135. Mazeika PK, Nadazdin A, Oakley CM. Dobutamine stress echocardiography for detection and assessment of coronary artery disease. J Am Coll Cardiol 1992;19:1203-11.
136. Segar DS, Brown SE, Sawada SG, et al. Dobutamine stress echocardiography: correlation with coronary lesion severity as determined by quantitative angiography. J Am Coll Cardiol 1992;19:1197-202.
137. Fioretti PM, Poldermans D, Salustri A, et al. Atropine increases the accuracy of dobutamine stress echocardiography in patients taking beta-blockers. Eur Heart J 1994;15:355-60.
138. Sharp SM, Sawada SG, Segar DS, et al. Dobutamine stress echocardiography: detection of coronary artery disease in patients with dilated cardiomyopathy. J Am Coll Cardiol 1994;24:934-9.
139. Bach DS, Muller DW, Gros BJ, et al. False positive dobutamine stress echocardiograms: characterization of clinical, echocardiographic and angiographic findings. J Am Coll Cardiol 1994;24:928-33.
140. Akosah KO, Porter TR, Simon R, et al. Ischemia-induced regional wall motion abnormality is improved after coronary angioplasty: demonstration by dobutamine stress echocardiography. J Am Coll Cardiol 1993;21:584-9.
141. Broderick T, Sawada S, Armstrong WF. Improvement in rest and exercise-induced wall motion abnormalities after coronary angioplasty: an exercise echocardiographic study. J Am Coll Cardiol 1990;15:591-9.
142. Davila-Roman VG, Wong AK, Li D, et al. Usefulness of dobutamine stress echocardiography for the prospective identification of the physiologic significance of coronary narrowings of moderate severity in patients undergoing evaluation for percutaneous transluminal coronary angioplasty. Am J Cardiol 1995;76:245-9.
143. Baker WB, Hays JT, Mahmarian JJ, et al. Comparison of dobutamine echocardiography with simultaneous thallium-201 single photon emission tomography (SPECT) in the diagnosis of coronary artery disease [abstract]. Circulation 1991;84:II-477.
144. Mairesse GH, Marwick TH, Vanoverschelde JL, et al. How accurate is dobutamine stress electrocardiography for detection of coronary artery disease? Comparison with two-dimensional echocardiography and technetium-99m methoxyl isobutyl isonitrile (mibi) perfusion scintigraphy. J Am Coll Cardiol 1994;24:920-7.
145. Davila-Roman VG, Waggoner AD, Sicard GA, et al. Dobutamine stress echocardiography predicts surgical outcome in patients with an aortic aneurysm and peripheral vascular disease. J Am Coll Cardiol 1993;21:957-63.
146. Poldermans D, Fioretti PM, Forster T, et al. Dobutamine stress echocardiography for assessment of perioperative cardiac risk in patients undergoing major vascular surgery. Circulation 1993;87:1506-12.
147. Zellner JL, Elliott BM, Robison JG, et al. Preoperative evaluation of cardiac risk using dobutamine-thallium imaging in vascular surgery. Ann Vasc Surg 1990;4:238-43.
148. Williams MJ, Odabashian J, Lauer MS, et al. Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction. J Am Coll Cardiol 1996;27:132-9.
149. Bigi R, Landi P, Pingitore A, et al. The prognostic value of dobutamine-atropine stress echocardiography early after acute myocardial infarction [abstract]. Circulation 1994;90:I-452.
150. Sonel AF, Sawada S, Kovacs R, et al. Assessment of post-infarction prognosis using dobutamine stress echocardiography [abstract]. Circulation 1994;90:I-453.
151. Young M, Weisner J, Mullane K. Arbutamine: a novel β-adrenoreceptor agonist for use in pharmacological stress testing. Drug Dev Res 1994;32:19-28.
152. Bach DS, Armstrong WF, and the International Arbutamine Study Group. Adequacy of low-stress arbutamine to provoke myocardial ischemia during echocardiography. Am J Cardiol 1995;76:259-62.
153. Dennis CA, Pool PE, Perrins EJ, et al. Stress testing with closed-loop arbutamine as an alternative to exercise. J Am Coll Cardiol 1995;26:1151-8.
154. Kiat H, Iskandrian AS, Villegas BJ, et al. Arbutamine stress thallium-201 single-photon emission computed tomography using a computerized closed-loop delivery system: multicenter trial for evaluation of safety and diagnostic accuracy. J Am Coll Cardiol 1995;26:1159-67.
155. Cohen JL, Chan KL, Jaarsma W, et al. Arbutamine echocardiography: efficacy and safety of a new pharmacologic stress agent to induce myocardial ischemia and detect coronary artery disease. J Am Coll Cardiol 1995;26:1168-75.
156. Lambertz H, Kreis A, Trumper H, et al. Simultaneous transesophageal atrial pacing and transesophageal two-dimensional echocardiography: a new method of stress echocardiography. J Am Coll Cardiol 1990;16:1143-53.
157. Kamp O, De Cock CC, Kupper AJ, et al. Simultaneous transesophageal two-dimensional echocardiography and atrial pacing for detecting coronary artery disease. Am J Cardiol 1992;69:1412-6.
158. Don Michael TA, Rao G, Balasingam S. Accuracy and usefulness of atrial pacing in conjunction with transesophageal echocardiography in the detection of cardiac ischemia (a comparative study with scintigraphic tomography and coronary arteriography). Am J Cardiol 1995;75:563-7.
159. Zabalgoitia M, Gandhi DK, Abi-Mansour P, et al. Transesophageal stress echocardiography: detection of coronary artery disease in patients with normal resting left ventricular contractility. Am Heart J 1991;122:1456-63.
160. Panza JA, Laurienzo JM, Curiel RV, et al. Transesophageal dobutamine stress echocardiography for evaluation of patients with coronary artery disease. J Am Coll Cardiol 1994;24:1260-7.
161. Baer FM, Voth E, Deutsch HJ, et al. Assessment of viable myocardium by dobutamine transesophageal echocardiography and comparison with fluorine-18 fluorodeoxy glucose positron emission tomography. J Am Coll Cardiol 1994;24:343-53.
162. Watada H, Ito H, Oh H, et al. Dobutamine stress echocardiography predicts reversible dysfunction and quantitates the extent of irreversibly damaged myocardium after reperfusion of anterior myocardial infarction. J Am Coll Cardiol 1994;24:624-30.
163. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 1982;66:1146-9.
164. Rahimtoola SH. A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. Circulation 1985;72:V-123-35.
165. Rahimtoola SH. The hibernating myocardium. Am Heart J 1989;117:211-21.
166. Braunwald E, Rutherford JD. Reversible ischemic left ventricular dysfunction: evidence for the "hibernating myocardium." J Am Coll Cardiol 1986;8:1467-70.
167. Eitzman D, al-Aouar Z, Kanter HL, et al. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol 1992;20:559-65.
168. Lemlek J, Heo J, Iskandrian AS. The clinical relevance of myocardial viability in patient management. Am Heart J 1992;124:1327-31.
169. Pigott JD, Kouchoukos NT, Oberman A, et al. Late results of surgical and medical therapy for patients with coronary artery disease and depressed left ventricular function. J Am Coll Cardiol 1985;5:1036-45.
170. Alderman EL, Fisher LD, Litwin P, et al. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation 1983;68:785-95.
171. Passamani E, Davis KB, Gillespie MJ, et al. A randomized trial of coronary artery bypass surgery: survival of patients with a low ejection fraction. N Engl J Med 1985;312:1665-71.
172. Montalescot G, Faraggi M, Drobinski G, et al. Myocardial viability in patients with Q wave myocardial infarction and no residual ischemia. Circulation 1992;86:47-55.
173. Bolli R. Myocardial "stunning" in man [review]. Circulation 1992;86:1671-91.
174. Bolli R. Oxygen-derived free radicals and postischemic myocardial dysfunction ("stunned myocardium") [review]. J Am Coll Cardiol 1988;12:239-49.
175. Stack RS, Phillips HR III, Grierson DS, et al. Functional improvement of jeopardized myocardium following intracoronary streptokinase infusion in acute myocardial infarction. J Clin Invest 1983;72:84-95.
176. Kusuoka H, Marban E. Cellular mechanisms of myocardial stunning [review]. Annu Rev Physiol 1992;54:243-56.
177. Engler R, Covell JW. Granulocytes cause reperfusion ventricular dysfunction after 15-minute ischemia in the dog. Circ Res 1987;61:20-8.
178. Renkin J, Wijns W, Ladha Z, et al. Reversal of segmental hypokinesis by coronary angioplasty in patients with unstable angina, persistent T wave inversion, and left anterior descending coronary artery stenosis: additional evidence for myocardial stunning in humans. Circulation 1990;82:913-21.
179. Camici P, Araujo LI, Spinks T, et al. Increased uptake of 18 F-fluorodeoxyglucose in post ischemic myocardium of patients with exercise induced angina. Circulation 1990;82:913-21.
180. Bolli R, Zhu W, Myers ML, et al. Beta-adrenergic stimulation reverses postischemic myocardial dysfunction without producing subsequent functional deterioration. Am J Cardiol 1985;56:964-8.
181. Pierard LA, De Landsheere CM, Berthe C, et al. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: comparison with positron emission tomography. J Am Coll Cardiol 1990;15:1021-31.
182. Barilla F, Gheorghiade M, Alam M, et al. Low-dose dobutamine in patients with acute myocardial infarction identifies viable but not contractile myocardium and predicts the magnitude of improvement in wall motion abnormalities in response to coronary revascularization. Am Heart J 1991;122:1522-31.
183. Previtali M, Poli A, Lanzarini L, et al. Dobutamine stress echocardiography for assessment of myocardial viability and ischemia in acute myocardial infarction treated with thrombolysis. Am J Cardiol 1993;72:124G-30G.
184. Duchak JM, Smart SC, Wynsen JC, et al. Low dose dobutamine induced infarction zone wall thickening correlates with thallium by delayed SPECT imaging [abstract]. Circulation 1992;86:I-384.
185. Ross J Jr. Myocardial perfusion-contraction matching: implications for coronary heart disease and hibernation. Circulation 1991;83:1076-83.
186. Lewis SJ, Sawada SG, Ryan T, et al. Segmental wall motion abnormalities in the absence of clinically documented myocardial infarction: clinical significance and evidence of hibernating myocardium. Am Heart J 1991;121:1088-94.
187. Horn HR, Teichholz LE, Cohn PF, et al. Augmentation of left ventricular contraction pattern in coronary artery disease by an inotropic catecholamine: the epinephrine ventriculogram. Circulation 1974;49:1063-71.
188. Popio KA, Gorlin R, Bechtel D, et al. Postextrasystolic potentiation as a predictor of potential myocardial viability: preoperative analyses compared with studies after coronary bypass surgery. Am J Cardiol 1977;39:944-53.
189. Schulz R, Guth BD, Pieper K, et al. Recruitment of an inotropic reserve in moderately ischemic myocardium at the expense of metabolic recovery: a model of short-term hibernation. Circ Res 1992;70:1282-95.
190. Cigarroa CG, deFilippi CR, Brickner ME, et al. Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization. Circulation 1993;88:430-6.
191. La Canna G, Alfiere O, Giubbini R, et al. Echocardiography during infusion of dobutamine for identification of reversible dysfunction in patients with chronic coronary artery disease. J Am Coll Cardiol 1994;23:617-26.
192. Perrone-Filardi P, Pace L, Prastaro M, et al. Dobutamine echocardiography predicts improvement of hypoperfused dysfunctional myocardium after revascularization in patients with coronary artery disease. Circulation 1995;91:2556-65.
193. Chen C, Li L, Chen LL, et al. Incremental doses of dobutamine induce a biphasic response in dysfunctional left ventricular regions subtending coronary stenoses. Circulation 1995;92:756-66.
194. Marzullo P, Parodi O, Reisenhofer B, et al. Value of rest thallium-201/technetium-99m sestamibi scans and dobutamine echocardiography for detecting myocardial viability. Am J Cardiol 1993;71:166-72.
195. Charney R, Schwinger ME, Chun J, et al. Dobutamine echocardiography and resting-redistribution thallium-201 scintigraphy predicts recovery of hibernating myocardium after coronary revascularization. Am Heart J 1994;128:864-9.
196. 201Tl single-photon emission computed tomography. Circulation 1995;91:2748-52.
197. 201Tl imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation 1993;87:1630-41.
198. Qureshi U, Afridi I, Vaduganathan P, et al. Prediction of recovery of function of hibernating myocardium after coronary angioplasty: comparison of dobutamine echocardiography and rest-redistribution thallium tomography [abstract]. J Am Coll Cardiol 1995;25:126A.
199. Stewart WJ, Aurigemma GP, Bierman FZ, et al. Task Force 4: training in echocardiography. J Am Coll Cardiol 1995;25:16-9.
200. Picano E, Lattanzi F, Orlandini A, et al. Stress echocardiography and the human factor: the importance of being expert. J Am Coll Cardiol 1991;17:666-9.
201. Perez JE, Waggoner AD, Davila Roman VG, et al. On line quantification of ventricular function during dobutamine stress echocardiography. Eur Heart J 1992;13:1669-76.
202. Sutherland GR, Stewart MJ, Groundstroem KWE, et al. Color Doppler myocardial imaging: a new technique for the assessment of myocardial function. J Am Soc Echocardiogr 1994;7:441-58.
203. Porter TR, Xie F, Kricsfeld A, et al. Improved endocardial border resolution during dobutamine stress echocardiography with intravenous sonicated dextrose albumin. J Am Coll Cardiol 1994;23:1440-3.
204. Dittrich HC, Armstrong WF, Perez JE, et al. Albunex enhances the interpretability of dobutamine stress echocardiographic images: blinded evaluation of multiple digitized cardiac cycles [abstract]. J Am Soc Echocardiogr 1995;8:355.
205. Sutherland GR, Grauer SE, Moran C, et al. Aerosomed MRX 115 echo contrast agent demonstrates myocardial opacification after intravenous injection in humans, without significant side effects, in a Phase I clinical trial [abstract]. Circulation 1995;92:I-463.
206. Dittrich HC, Kuvelas T, Dadd K, et al. Safety and efficacy of the ultrasound contrast agent FS069 in normal humans: results of a Phase One trial [abstract]. Circulation 1995;92:I-464.
207. Von Bibra H, Tuchnitz A, Klein A, et al. Stress test with pulsed Doppler velocity mapping of left ventricular myocardium [abstract]. Circulation 1995;92:I-88.
208. Von Bibra H, Tuchnitz A, Firscheke C, et al. Doppler tissue imaging of left ventricular myocardium: initial results during pharmacologic stress [abstract]. J Am Coll Cardiol 1995;25:57A.